Pericarditis has been recognised as a clinical feature of uraemia for over 100 years, and frequently was a harbinger of death in the era before dialysis (Beaudry et al., 1966) . More recently, recognition and treatment of uraemic pericarditis and its complications have allowed more patients to survive acute episodes and continue to be maintained on chronic haemodialysis.
Echocardiography has gained widespread use for the non-invasive detection of pericardial effusion (Feigenbaum, 1972) . Careful echocardiographic evaluation may reliably define effusions as small as 20 ml (Horowitz et al., 1974) . We were initially impressed by the apparently high prevalence of pericardial effusion among patients on maintenance haemodialysis referred for echocardiography because clinical symptoms suggested pericardial disease.
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Received for publication 19 July 1977 sustained volume overload. As long as such effusions were small and did not cause circulatory embarrassment, they would remain clinically silent and undetected. If this were the case, then the echocardiographic demonstration of effusion in patients on chronic dialysis would be of different clinical import than if subclinical effusions were uncommon. The current study was undertaken to define more clearly the significance of the echocardiographic demonstration of pericardial effusion in these patients and to clarify the role of echocardiography in their management.
Methods
Thirty-five asymptomatic, stable patients comprising the total group who had been dialysed chronically in our unit for at least 2 months (range 2 to 72 months) underwent echocardiographic examination during a 4-month study period (group A). None had any evidence of pericarditis during the study period. Of these 35 patients, 6 had had previous echocardiographic studies to rule out pericardial effusion at least 6 months before their group.bmj.com on April 13, 2017 -Published by http://heart.bmj.com/ Downloaded from 12ay H. Kleiman, Jorge Motta, Elizabeth London, J. Phillip Pennell, and Richard L. Popp patient's chest was raised approximately 30°from the horizontal, in the supine or shallow (300) left lateral decubitus position. The transducer was placed in the third, fourth, or fifth intercostal space at the left sternal border. The chosen transducer position permitted recording of the echoes from the mitral valve leaflets while the transducer was perpendicular to the chest wall in the sagittal plane. Inferolateral angulation of the transducer from this position allowed recording of the echoes from the ventricular structures.
A technically satisfactory study was defined as the simultaneous recording of echoes from the posterior left ventricular pericardium, epicardium, endocardium, mitral chordae tendineae, interventricular septum, and anterior heart wall. In order to locate the strong pericardial echo, the damping control was abruptly increased after the optimal gain settings for the ventricular structures had been achieved (Feigenbaum, 1972) . Continuous recording of this area over several cardiac cycles at maximal damping permitted the clear observation of isolated pericardial movement. Slightly less damping often brought out the epicardium and occasionally a small separation between the posterior epicardium and pericardium. As the damping was further reduced, this small separation often was obscured. Minimal damping allowed identification of all ventricular structures and verified the patterns of pericardial, epicardial, and endocardial echoes of a satisfactory study. The volume of pericardial fluid was estimated as described by Horowitz et al. (1974) .
In order to attempt to determine if myocardial contractility was altered in uraemic patients at the time that effusions were present, the fractional shortening was measured in symptomatic and asymptomatic patients. The left ventricular internal diameters at end-diastole (LVIDd) and end-systole (LVID5) were measured and used to calculate fractional shortening (FS), an index of circumferential myocardial contractility (McDonald et al., 1972; McDonald, 1976) 
Results
Of the 35 asymptomatic patients in group A, 4 (11 %) had pericardial effusions and only 2 (6%) had effusions estimated as more than 100 ml (Horowitz et al., 1974) (Fig. 1-3 ). This was in distinct contrast to the findings among the sympto- (Fig. 3) .
Records of excellent technical quality satisfactory for calculation of fractional shortening were obtained in 23 patients in group A and 39 patients in group B (Table) . Mean values for fractional shortening were similar among symptomatic patients with or without pericardial effusions, but the values were less than those among asymptomatic patients (Table) . Eleven patients with effusions had multiple (2 to 7) echocardiographic examinations performed, either to follow the course of a single effusion or to assess several episodes of pericardial disease. Improvement or deterioration in ventricular function as measured by fractional shortening did not correlate with changes in the volume of effusion in this small series.
Discussion
Uraemic pericarditis continues to cause significant morbidity and mortality among patients in haemodialysis programmes (Bailey et al., 1968; Comty et al., 1971; Baldwin and Edwards, 1976) . Past studies of clinically evident uraemic pericarditis have indicated a prevalence of between 16 and 41 per cent among patients in chronic dialysis programmes. Many patients have developed pericarditis 3 months or longer after starting dialysis, in spite of technically adequate and frequent dialysis (Beaudry et al., 1966; Bailey et al., 1968; Comty et al., 1971 group.bmj.com on April 13, 2017 -Published by http://heart.bmj.com/ Downloaded from assessment of rises in the jugular venous pulse has proved unreliable because obvious and sometimes rapid changes in intravascular volume are associated with dialysis. Several investigators have observed that measurements of blood urea nitrogen or creatinine do not predict the patients who will develop pericarditis (Comty et al., 1971) .
With the advent of echocardiography, a simple, sensitive, and uniformly safe method to diagnose pericardial effusion has become available. We used echocardiography to study prospectively a group of asymptomatic stable patients undergoing chronic haemodialysis. This method allows reliable identification of patterns associated with even small amounts of pericardial fluid, but we did not attempt to quantify the volume of effusion when the echocardiographic pattern suggested only 20 ml to 100 ml of pericardial fluid. Unsuspected effusions of 100 ml or larger were infrequent (6 %). For comparison, the echocardiograms were reviewed from 41 patients who had symptoms suggestive of pericardial disease at the time of study. In 51 per cent of these patients, pericardial effusions were shown, and in 37 per cent the effusions were estimated to be greater than 100 ml. These observations imply that when clinical findings suggest pericardial disease, the echocardiographic demonstration of 100 ml or more of pericardial fluid is highly indicative of new effusion, rather than of coincidental pre-existing effusion. We believe such patients warrant careful and continuing clinical observation, as well as frequent echocardiographic follow-up.
Necropsy studies of patients who have died as a result of uraemic pericarditis have shown evidence of an associated myocarditis, suggesting possible impairment of ventricular function (Langendorf and Pirani, 1947; Gouley, 1940; Baldwin and Edwards, 1976) . Our current echocardiographic assessment of left ventricular function in small numbers of patients showed that fractional shortening was not uniformly depressed when pericardial effusions were present, and that changes in left ventricular performance did not parallel changes in the volume of pericardial effusion measured echocardiographically. The measurement of change in left ventricular dimensions is subject to error in those patients with sufficient pericardial effusion to allow the heart to swing about within the pericardium, so the sound beam strikes different parts of the walls at end-diastole and end-systole. It is interesting that the patients with symptoms but no effusion had the lowest values for fractional shortening. Additional prospective studies of larger numbers of patients with end-stage renal disease will be necessary to clarify these findings.
